Document is current
Any future updates will be listed below
-
Authors
Su, Longxiang
Yang, Yingying
Wang, Ye
Lan, Jinyan
Yue, Chaofu
Yang, Mei
Pensier, Joris
Zhang, Song
Yang, Jin
Zhang, Jicheng
Shao, Huanzhang
Wang, Yu
Zhao, Jiangyong
Song, Xiaojun
Cao, Haiquan
Wu, Huiping
Cai, Fuhong
Ma, Yue
Song, Zhangwei
Talmor, Daniel
Baedorf-Kassis, Elias
Long, Yun
-
Funding
Funding for this research was provided by:
National High-Level Hospital Clinical Research Funding (2025-PUMCH-A-201)
CAMS Innovation Fund for Medical Sciences (2023-I2M-CT-B-031)
- License Information
-
More Information
Article History
Received: 29 December 2025
Accepted: 2 June 2026
First Online: 4 July 2026
Declarations
:
: The study has received central ethics approval from the Institutional Review Board of Peking Union Medical College Hospital (approval number: K25C0798), and all participating sites have obtained local ethics approval. The REALVENT trial entered the initiation phase in the late December 2025. Site training, system integration, and investigator meetings were completed before study initiation. Recruitment began in January 2026. The planned recruitment duration is 12 months, with trial completion anticipated by the end of 2026 or early 2027, followed by data cleaning, statistical analysis, and dissemination. The trial was prospectively registered at ClinicalTrials.gov (Identifier: NCT07307066; registration date: 2 December 2025).
: All authors contributed to manuscript revision, approved the final version, and agree to be accountable for the integrity and accuracy of the work.
: The authors declare no competing interests.
